Identifying the key genes of Epstein–Barr virus‐regulated tumour immune microenvironment of gastric carcinomas
Cell Proliferation · 2023-03 · 56 (3)
DOI: 10.1111/cpr.13373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 14.12.2022. Verfasst von Heng Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center of Regenerative Medicine & Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Stomach Neoplasms, Carcinoma. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chutian Researcher Project, Wuhan Yingcai Project.
Abstract (Originalsprache)
The Epstein–Barr virus (EBV) is involved in the carcinogenesis of gastric cancer (GC) upon infection of normal cell and induces a highly variable composition of the tumour microenvironment (TME). However, systematic bioinformatics analysis of key genes associated with EBV regulation of immune infiltration is still lacking. In the present study, the TCGA and GEO databases were recruited to analyse the association between EBV infection and the profile of immune infiltration in GC. The weighted gene co‐expression analysis (WGCNA) was applied to shed light on the key gene modules associated with EBV‐associated immune infiltration in GC. 204 GC tissues were used to analysed the expression of key hub genes by using the immunohistochemical method. Real‐time PCR was used to evaluate the association between the expression of EBV latent/lytic genes and key immune infiltration genes. Our results suggested that EBV infection changed the TME of GC mainly regulates the TIICs. The top three hub genes of blue (GBP1, IRF1, and LAP3) and brown (BIN2, ITGAL, and LILRB1) modules as representative genes were associated with EBV infection and GC immune infiltration. Furthermore, EBV‐encoded LMP1 expression is account for the overexpression of GBP1 and IRF1. EBV infection significantly changes the TME of GC, and the activation of key immune genes was more dependent on the invasiveness of the whole EBV virion instead of single EBV latent/lytic gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center of Regenerative Medicine & Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China.
- College of Life and Health Sciences, Institute of Biology and Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.
- Department of Pathology, Guilin Medical University, Guilin, Guangxi, China.
- Foshan Hospital of Stomatology, School of Medicine, Foshan University, Foshan, Guangdong, China.
- Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Demonstration Center for Experimental Basic Medicine Education, Wuhan University, Wuhan, China.
ORCID-Profile: Yan He, Qingsong Ye
Förderung
- Chutian Researcher Project
- Wuhan Yingcai Project
Zitieren
APA
Zhou, H., Jing, S., Liu, Y., Wang, X., Duan, X., Xiong, W., Li, R., Peng, Y., Ai, Y., Fu, D., Wang, H., Zhu, Y., Zeng, Z., He, Y., & Ye, Q. (2023). Identifying the key genes of Epstein–Barr virus‐regulated tumour immune microenvironment of gastric carcinomas. Cell Proliferation, 56(3). https://doi.org/10.1111/cpr.13373
Vancouver
Zhou H, Jing S, Liu Y, Wang X, Duan X, Xiong W, et al. Identifying the key genes of Epstein–Barr virus‐regulated tumour immune microenvironment of gastric carcinomas. Cell Proliferation. 2023;56(3). doi:10.1111/cpr.13373
BibTeX
@article{Zhou2023,
author = {Zhou, Heng and Jing, Shuili and Liu, Yu and Wang, Xuming and Duan, Xingxiang and Xiong, Wei and Li, Ruohan and Peng, Youjian and Ai, Yilong and Fu, Dehao and Wang, Hui and Zhu, Yaoqi and Zeng, Zhi and He, Yan and Ye, Qingsong},
title = {Identifying the key genes of Epstein–Barr virus‐regulated tumour immune microenvironment of gastric carcinomas},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {3},
doi = {10.1111/cpr.13373}
}
EUVIMED